{"id":386510,"date":"2020-11-23T07:03:31","date_gmt":"2020-11-23T12:03:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386510"},"modified":"2020-11-23T07:03:31","modified_gmt":"2020-11-23T12:03:31","slug":"myovant-sciences-to-present-at-upcoming-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/","title":{"rendered":"Myovant Sciences to Present at Upcoming December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BASEL, Switzerland, Nov.  23, 2020  (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Evercore ISI 3<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual HealthCONx Virtual Conference<\/strong> on December 1, 2020 at 4:45 p.m. Eastern time. Lynn Seely, M.D., chief executive officer of Myovant Sciences, Inc., and Frank Karbe, president and chief financial officer of Myovant Sciences, Inc., will participate in a webcast presentation. Management will also participate in virtual one-on-one investor meetings on December 1. <\/p>\n<\/li>\n<li>\n          <strong>Piper Sandler 32<\/strong><br \/>\n          <sup><br \/>\n            <strong>nd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Virtual Healthcare Conference<\/strong>. A pre-recorded presentation by Dr. Seely will be available at 10 a.m. Eastern time today on the investor relations page of Myovant\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iNmyChvZcHmVDjvKTNtcj_e1TEsb2DqkdzOFqG74OE1n4mGyhEMi52c7OMCTvsz-k3MvAVEqXhMW7XAwvBfwWg1VRHn1pi1S2azsZuObBtQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors.myovant.com<\/a>. Management will participate in virtual one-on-one investor meetings on December 3, 2020.<\/li>\n<\/ul>\n<p>The presentations will be accessible on the Events page under the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yBqEUC8mhBGzEG_JOmb-v-nPS2tYBQXVMLreNReOetz1PVpRXaM7IWfnorTRaWgG3c_96YRbnvQhfUy6SZOfOEGJ_HTLg0el_h7LeJgVY8Mn-9s-Kix-H0ksxu8O6W25KLjCzJ0aIFqmwyaStiKkREFC1lh_j9fD-Cohcgr94P7uhxUBUDchXSwhgk2s6IOrcrUAPWD8amYP0Qq5L1I_25il7qjamJBchx44hC7XNu9W2K5ysOhFkekjJfQtIaCiGCOl9e0j-TWkcrg4IWZYOw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Investors &amp; Media<\/a>\u00a0section of the\u00a0Myovant\u00a0website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yJ24qwMAKq8okS8LXbqRKWVNzXJPofStNJ9i23CygG8atQOsuzXjanm_5qBbITU2ZiWpyi9VXjL84JW1at7ASEcHpHP3SXooL6WDV5l47Z7I0Lmn-EgeCxNcGP2P0NvOsep9beQJ2Hnfh6a0_faKf6vrhZx3Bn1T2gNMn3rM31k9XK0b1HegEKEBELHsfFZHEHwinLm2gCjGfp_b6sfGJo_55GN_DTs3jsCE_ZuMLWk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.myovant.com<\/a>.<\/p>\n<p>\n        <strong>About Myovant Sciences<\/strong><br \/>\n        <br \/>Myovant Sciences\u00a0aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Our lead product candidate, relugolix, is a once-daily, oral GnRH receptor antagonist. Relugolix monotherapy tablet (120 mg) is under regulatory review in the\u00a0U.S.\u00a0for men with advanced prostate cancer. Relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) is under regulatory review in\u00a0Europe\u00a0and the\u00a0U.S.\u00a0for women with uterine fibroids and is under development for women with endometriosis. We are also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction.\u00a0Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is our majority shareholder. For more information, please visit our website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yJ24qwMAKq8okS8LXbqRKfB8VOcmRW3LkrbaWpaz7l_w7JXM4WWGGIgEnH0y9_C8hySkJXqv13f3L7OWv8yjxfHmLXcQB_iMF5hgn0pk6xKsuXjblpD-LVjGQK9ACFeDfdL7KmLIpDz8inZniwOI7VUlOg9526HHLCPl3WY9WmtiVrjAjsBt8pi9N94K-SRqXynTqj3RRXB9_Js-2KBAZqb-cO3W3kgTI9nwsGnitIA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.myovant.com<\/a>. Follow\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4mcC_V2WGQx8aCjcOLZe_NUMkrlhrdg9QWraMPJwqAj1HglSrc3oF-kn05Ej3WUijQ8IHIZIAjG4lGpkg33Idp1fb3oj6sQ_c2J7g5tSPwDOQ0uJsTKWCyZV-3WMGaqxgH1Mi4-pVasJVBoheP6E7nVR06FCZHAJOjlUt0Igg1CPYlocKlRqo-8FS2-GcY8IvLdcuwoN6jeSWdQ3ohCpeGFpkVnwMtekjD_5vx7hLTs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">@Myovant<\/a>\u00a0on Twitter and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nQbbKDIMU4J1N5apMQXYMZhaHYOdbade3uRDizn8_GJMH0QuYf_OV0NoO-MFdaMQ_TY8SrGf_z-2SI7JyBvUWra4u13LL7kwlN5c3fOE73_B9zraYSy7BdL8LuzVFY711NhodNHg7tQUXhWqys90ndO2IuQTH07k2hpi9JpgYLVTRTP2ohoVW4FZXrZ0acXOwPkpU-z22eDNzoDojbNRjh-4rVPxohIV74lqvTYzR9z9izwHH-JYSOVMIlDOyJ-h\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Ryan Crowe<br \/>Vice President, Investor Relations<br \/>Myovant Sciences, Inc. <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o7ud9jjy-ZveHiT_IRSRuyZmx2mMosVl9sn0muTS56MlPI0POvXW3wJKMlNTnF2WszK5JK7T7LiHSvxVaaPHswbA6fncqBcPDc_yy2ZXNYY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@myovant.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Albert Liao<br \/>Director, Corporate Communications<br \/>Myovant Sciences, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mXJivM-sMVuI6KjLPcI2XXXOQjRfTjKtYL1J__8QtPkW0VLSjLPEZI9nV4NUYp7PWClAbFip9lFlxCrEmnePTQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">media@myovant.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6cc3d9fe-12fa-487d-95e4-c59d84ce94ca\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASEL, Switzerland, Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences: Evercore ISI 3 rd Annual HealthCONx Virtual Conference on December 1, 2020 at 4:45 p.m. Eastern time. Lynn Seely, M.D., chief executive officer of Myovant Sciences, Inc., and Frank Karbe, president and chief financial officer of Myovant Sciences, Inc., will participate in a webcast presentation. Management will also participate in virtual one-on-one investor meetings on December 1. Piper Sandler 32 nd Annual Virtual Healthcare Conference. A pre-recorded presentation by Dr. Seely will be available at 10 a.m. Eastern time today on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myovant Sciences to Present at Upcoming December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386510","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myovant Sciences to Present at Upcoming December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myovant Sciences to Present at Upcoming December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASEL, Switzerland, Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences: Evercore ISI 3 rd Annual HealthCONx Virtual Conference on December 1, 2020 at 4:45 p.m. Eastern time. Lynn Seely, M.D., chief executive officer of Myovant Sciences, Inc., and Frank Karbe, president and chief financial officer of Myovant Sciences, Inc., will participate in a webcast presentation. Management will also participate in virtual one-on-one investor meetings on December 1. Piper Sandler 32 nd Annual Virtual Healthcare Conference. A pre-recorded presentation by Dr. Seely will be available at 10 a.m. Eastern time today on the &hellip; Continue reading &quot;Myovant Sciences to Present at Upcoming December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-23T12:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myovant Sciences to Present at Upcoming December Investor Conferences\",\"datePublished\":\"2020-11-23T12:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/\"},\"wordCount\":335,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/\",\"name\":\"Myovant Sciences to Present at Upcoming December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=\",\"datePublished\":\"2020-11-23T12:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myovant Sciences to Present at Upcoming December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myovant Sciences to Present at Upcoming December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Myovant Sciences to Present at Upcoming December Investor Conferences - Market Newsdesk","og_description":"BASEL, Switzerland, Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Myovant Sciences (NYSE:\u00a0MYOV), a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences: Evercore ISI 3 rd Annual HealthCONx Virtual Conference on December 1, 2020 at 4:45 p.m. Eastern time. Lynn Seely, M.D., chief executive officer of Myovant Sciences, Inc., and Frank Karbe, president and chief financial officer of Myovant Sciences, Inc., will participate in a webcast presentation. Management will also participate in virtual one-on-one investor meetings on December 1. Piper Sandler 32 nd Annual Virtual Healthcare Conference. A pre-recorded presentation by Dr. Seely will be available at 10 a.m. Eastern time today on the &hellip; Continue reading \"Myovant Sciences to Present at Upcoming December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-23T12:03:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myovant Sciences to Present at Upcoming December Investor Conferences","datePublished":"2020-11-23T12:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/"},"wordCount":335,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/","name":"Myovant Sciences to Present at Upcoming December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=","datePublished":"2020-11-23T12:03:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQxOSMzODM5MDY1IzIxNzcyNDg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myovant-sciences-to-present-at-upcoming-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myovant Sciences to Present at Upcoming December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386510"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386510\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}